NUVB Insider Trading Activity and SEC Form 4 Filings
NUVB insider trading summary
Over the past 12 months, insiders at Nuvation Bio Inc. (NUVB) reported 14 sales worth $8.7M by 6 insiders and 1 open-market purchase worth $118K by 1 insider on SEC Form 4. Net insider selling was $8.6M.
Latest NUVB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Gary Hattersley | Chief Scientific Officer | Sell | $709K (100,000 @ $7.09) |
| Jun 23, 2026 | Stacy Markel | Chief People Officer | Sell | $753K (125,000 @ $6.03) |
| Jun 23, 2026 | Kerry Wentworth | Chief Regulatory Officer | Sell | $379K (63,000 @ $6.02) |
| Jun 23, 2026 | Philippe Sauvage | Chief Financial Officer | Sell | $286K (47,668 @ $6.01) |
| Jun 9, 2026 | Robert Mashal | Insider | Buy | $118K (25,000 @ $4.73) |
| Apr 6, 2026 | Kerry Wentworth | Chief Regulatory Officer | Sell | $904K (200,000 @ $4.52) |
| Dec 1, 2025 | Dongfang Liu | Chief Medical Officer | Sell | $1.2M (150,000 @ $7.82) |
| Nov 26, 2025 | Dongfang Liu | Chief Medical Officer | Sell | $80K (10,000 @ $8.00) |
| Nov 25, 2025 | Dongfang Liu | Chief Medical Officer | Sell | $75K (10,000 @ $7.50) |
| Nov 20, 2025 | Gary Hattersley | Chief Scientific Officer | Sell | $499K (69,051 @ $7.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.